Press "Enter" to skip to content

New patent expiration for Abbvie Inc drug VIEKIRA PAK (COPACKAGED)

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie Inc drug VIEKIRA PAK (COPACKAGED)

Annual Drug Patent Expirations for VIEKIRA+PAK+%28COPACKAGED%29
Annual Drug Patent Expirations for VIEKIRA+PAK+%28COPACKAGED%29

Viekira Pak (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.

Drug patent litigation for VIEKIRA PAK (COPACKAGED).

This drug has five hundred and forty patent family members in fifty-three countries.

The generic ingredient in VIEKIRA PAK (COPACKAGED) is dasabuvir sodium; ombitasvir; paritaprevir; ritonavir. One supplier is listed for this compound. Additional details are available on the dasabuvir sodium; ombitasvir; paritaprevir; ritonavir profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Abbvie Inc drug VIEKIRA PAK (COPACKAGED)
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions